“…Recently, there have been significant developments in highly sensitive molecular point-of-care tests for flaviviruses, such as reverse transcription loop-mediated isothermal amplification (RT-LAMP), reverse transcription recombinase polymerase amplification (RT-RPA), nucleic acid sequence-based amplification (NASBA), transcription-mediated amplification (TMA), helicase-dependent amplification (HDA), and nicking enzyme amplification reaction (NEAR) (Calvert et al, 2017;Ganguli et al, 2017;Kurosaki et al, 2017;Mauk et al, 2017;Priye et al, 2017;Yaren et al, 2018;Castro et al, 2018;Guo et al, 2018;Kim et al, 2018a;Kumar et al, 2018;Lopez-Jimena et al, 2018;Lamb et al, 2018;Sabalza et al, 2018;Song et al, 2018;Zhao and Feng, 2019;Abd et al, 2017;Chan et al, 2018;Tan et al, 2018;Vasileva Wand et al, 2018;Saa et al, 2018). Microfluidics, chips, paper-based devices, and biosensors are also being developed (Onyango et al, 2017;Adegoke et al, 2017;Afsahi et al, 2018;Ariffin et al, 2018;Wasik et al, 2017).…”